So, from the peak to correct around 15% kinds is I would say, but beyond that I would say then they start looking attractive again from a three to five years perspective because none of the problems are really balance sheet oriented problems, they are all more P&L related problems and more valuation issues.
Molbio Diagnostics shares rally 9% as Jefferies initiates ‘high conviction top pick’ call for recently listed stock. Why is it bullish?
Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerage set a Rs 1,600